Year |
Citation |
Score |
2020 |
Chirshev E, Hojo N, Bertucci A, Sanderman L, Nguyen A, Wang H, Suzuki T, Brito E, Martinez SR, Castañón C, Mirshahidi S, Vazquez ME, Wat P, Oberg KC, Ioffe YJ, et al. Epithelial/mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with miRNA let-7 levels and predicts tumor growth and metastasis. Molecular Oncology. PMID 32652647 DOI: 10.1002/1878-0261.12762 |
0.304 |
|
2020 |
Unternaehrer J, Chirshev E, Hojo N, Bertucci A, Sanderman L, Nguyen A, Wang H, Suzuki T, Brito E, Martine S, Castañón C, Mirshahidi S, Vazquez M, Oberg KC, Ioffe YJ. Abstract 1682: Epithelial-mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with let-7 levels and predicts tumor growth and metastasis Cancer Research. 80: 1682-1682. DOI: 10.1158/1538-7445.Am2020-1682 |
0.318 |
|
2019 |
Mirshahidi S, de Necochea-Campion R, Moretta A, Williams NL, Reeves ME, Otoukesh S, Mirshahidi HR, Khosrowpour S, Duerksen-Hughes P, Zuckerman LM. Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line . Cancer Investigation. 1-29. PMID 31770037 DOI: 10.1080/07357907.2019.1698592 |
0.318 |
|
2018 |
Shouse GP, Necochea-Campion Rd, Mirshahidi S, Chen C, Payne KJ. Abstract 5442: Dose-dependent toxicity of FTY720, a sphingosine-1-phosphate receptor agonist, on double hit lymphoma cells via PP2A-mediated dephosphorylation of c-myc and bcl-2 Cancer Research. 78: 5442-5442. DOI: 10.1158/1538-7445.Am2018-5442 |
0.338 |
|
2017 |
Simental A, Lee S, Filho PADA, Peterson NR, Mirshahidi S, Duerksen-Hughes P, Yuan X. Abstract 60: Characterization of papillary thyroid carcinoma primary cell culture derived cancer stem-like cells Clinical Cancer Research. 23: 60-60. DOI: 10.1158/1557-3265.Aacrahns17-60 |
0.343 |
|
2017 |
Sanchez TW, Zhang G, Li J, Dai L, Kellow R, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang J, Casiano C. Abstract B05: Differential autoimmune response to glycolysis and plasminogen antigens from aggressive prostate cancer cells in African American and European American men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-B05 |
0.327 |
|
2016 |
Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang JY, Casiano CA. Immunoseroproteomic profiling in African American men with prostate cancer: evidence for an autoantibody response to glycolysis and plasminogen-associated proteins. Molecular & Cellular Proteomics : McP. PMID 27742740 DOI: 10.1074/Mcp.M116.060244 |
0.304 |
|
2016 |
Sanchez TW, Li J, Dai L, Mirshahidi S, Zhang G, Wall N, Wilson C, Montgomery S, Zhang J, Casiano C. Abstract B05: Immunoproteomic profiling in African American men with prostate cancer: Evidence for an autoimmune response to glycolytic enzymes Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B05 |
0.307 |
|
2016 |
Sanchez TW, Zhang J, Dai L, Montgomery S, Wilson C, Zhang G, Mirshahidi S, Wall N, Casiano CA. Abstract 3895: Immunoproteomic profiling in African American men with prostate cancer: Evidence for an autoimmune response to glycolytic enzymes Cancer Research. 76: 3895-3895. DOI: 10.1158/1538-7445.Am2016-3895 |
0.305 |
|
2015 |
de Necochea-Campion R, Diaz Osterman CJ, Hsu HW, Fan J, Mirshahidi S, Wall NR, Chen CS. AML sensitivity to YM155 is modulated through AKT and Mcl-1. Cancer Letters. PMID 26118775 DOI: 10.1016/J.Canlet.2015.05.034 |
0.317 |
|
2015 |
Sanchez TW, Mirshahidi S, Wall N, Wilson C, Montgomery S, Casiano CA. Abstract B03: Identification of alpha-enolase as a candidate tumor associated autoantigen in African American men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B03 |
0.3 |
|
2015 |
Sanchez TW, Agyeman K, Mirshahidi S, Wall N, Wilson C, Montgomery S, Casiano CA. Abstract 1831: Identification of alpha-enolase and annexin as candidate tumor-associated antigens by immunoseroproteomic profiling of autoantibodies in African American and Caucasian men with prostate cancer Cancer Research. 75: 1831-1831. DOI: 10.1158/1538-7445.Am2015-1831 |
0.301 |
|
2014 |
Sanchez TW, Mirshahidi S, Wall NR, Wilson C, Montgomery S, Casiano CA. Abstract C10: Immunoseroproteomic profiling of autoantibodies to tumor-associated autoantigens in African American and Caucasian men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C10 |
0.301 |
|
2013 |
Necochea-Campion Rd, Chen CS, Mirshahidi S, Howard FD, Wall NR. Clinico-pathologic relevance of Survivin splice variant expression in cancer Cancer Letters. 339: 167-174. PMID 23791888 DOI: 10.1016/J.Canlet.2013.06.007 |
0.304 |
|
2013 |
Hsu HW, Gridley DS, Kim PD, Hu S, de Necochea-Campion R, Ferris RL, Chen CS, Mirshahidi S. Linifanib (ABT-869) enhances radiosensitivity of head and neck squamous cell carcinoma cells. Oral Oncology. 49: 591-7. PMID 23490884 DOI: 10.1016/J.Oraloncology.2013.02.009 |
0.34 |
|
2010 |
Sadegh-Nasseri S, Dalai SK, Korb Ferris LC, Mirshahidi S. Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy. Immunology. 129: 1-7. PMID 20002785 DOI: 10.1111/J.1365-2567.2009.03206.X |
0.756 |
|
2009 |
Mirshahidi S, Kramer VG, Whitney JB, Essono S, Lee S, Dranoff G, Anderson KS, Ruprecht RM. Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival. Vaccine. 27: 1825-33. PMID 19201387 DOI: 10.1016/J.Vaccine.2009.01.089 |
0.451 |
|
2008 |
Dalai SK, Mirshahidi S, Morrot A, Zavala F, Sadegh-Nasseri S. Anergy in memory CD4+ T cells is induced by B cells. Journal of Immunology (Baltimore, Md. : 1950). 181: 3221-31. PMID 18713993 DOI: 10.4049/Jimmunol.181.5.3221 |
0.731 |
|
2008 |
Chou CL, Mirshahidi S, Su KW, Kim A, Narayan K, Khoruzhenko S, Xu M, Sadegh-Nasseri S. Short peptide sequences mimic HLA-DM functions. Molecular Immunology. 45: 1935-43. PMID 18054387 DOI: 10.1016/J.Molimm.2007.10.033 |
0.579 |
|
2008 |
Mirshahidi S, Kramer V, Whitney J, Dranoff G, Anderson K, Ruprecht R. Su.63. Using Overlapping Synthetic Peptides from Tumor-associated Protein Antigens for Breast Cancer Vaccine Development Clinical Immunology. 127: S144-S145. DOI: 10.1016/J.Clim.2008.03.414 |
0.373 |
|
2006 |
Jiang S, Song R, Popov S, Mirshahidi S, Ruprecht RM. Overlapping synthetic peptides as vaccines. Vaccine. 24: 6356-65. PMID 16793181 DOI: 10.1016/J.Vaccine.2006.04.070 |
0.442 |
|
2004 |
Mirshahidi S, Ferris LC, Sadegh-Nasseri S. The magnitude of TCR engagement is a critical predictor of T cell anergy or activation. Journal of Immunology (Baltimore, Md. : 1950). 172: 5346-55. PMID 15100274 DOI: 10.4049/Jimmunol.172.9.5346 |
0.738 |
|
2001 |
Mirshahidi S, Huang C, Sadegh-Nasseri S. Anergy in peripheral memory CD4+ T cells induced by low avidity engagement of T cell receptor Journal of Experimental Medicine. 194: 719-731. PMID 11560989 DOI: 10.1084/Jem.194.6.719 |
0.692 |
|
Show low-probability matches. |